deaths from compounded semaglutide Recent reports link around 10 and 100 hospitalizations in the U.S. to versions of semaglutide, sold under the brand name Ozempic by Novo Nordisk. The company has raised concerns with Semaglutide Overdose Risk: Safety Facts
Description
Weight loss solutions with compounded GLP-1 medications like Semaglutide and Tirzepatide
Can GLP-1 medications affect pleasure and motivation
Introduction and Importance Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), is increasingly used for glycemic control, weight loss, and cardiovascular risk reduction
It is a major therapeutic target for type 2 diabetes and obesity
Some people taking semaglutide report feeling colder than usual
